219 related articles for article (PubMed ID: 16119673)
21. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
[TBL] [Abstract][Full Text] [Related]
22. A study of the prevalence of systemic sclerosis in northeast England.
Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID
Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101
[TBL] [Abstract][Full Text] [Related]
23. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement.
Yazawa N; Fujimoto M; Kikuchi K; Kubo M; Ihn H; Sato S; Tamaki T; Tamaki K
J Rheumatol; 1998 Apr; 25(4):650-3. PubMed ID: 9558164
[TBL] [Abstract][Full Text] [Related]
24. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
[TBL] [Abstract][Full Text] [Related]
25. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
[TBL] [Abstract][Full Text] [Related]
26. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
Sato LT; Kayser C; Andrade LE
Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
[TBL] [Abstract][Full Text] [Related]
27. The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.
Morrisroe KB; Stevens W; Nandurkar H; Prior D; Thakkar V; Roddy J; Zochling J; Sahhar J; Tymms K; Sturgess A; Major G; Kermeen F; Hill C; Walker J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-133-7. PubMed ID: 24564981
[TBL] [Abstract][Full Text] [Related]
28. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
[TBL] [Abstract][Full Text] [Related]
29. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous and serologic subsets of systemic sclerosis.
Ferri C; Bernini L; Cecchetti R; Latorraca A; Marotta G; Pasero G; Neri R; Bombardieri S
J Rheumatol; 1991 Dec; 18(12):1826-32. PubMed ID: 1795320
[TBL] [Abstract][Full Text] [Related]
31. Juvenile systemic sclerosis: a follow-up study of eight patients.
Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
[TBL] [Abstract][Full Text] [Related]
32. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.
Balada E; Simeón-Aznar CP; Ordi-Ros J; Rosa-Leyva M; Selva-O'Callaghan A; Pardos-Gea J; Fonollosa-Pla V; Vilardell-Tarrés M
Ann Rheum Dis; 2008 Jul; 67(7):1027-9. PubMed ID: 18272670
[TBL] [Abstract][Full Text] [Related]
33. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Tamby MC; Chanseaud Y; Humbert M; Fermanian J; Guilpain P; Garcia-de-la-Peña-Lefebvre P; Brunet S; Servettaz A; Weill B; Simonneau G; Guillevin L; Boissier MC; Mouthon L
Thorax; 2005 Sep; 60(9):765-72. PubMed ID: 16135682
[TBL] [Abstract][Full Text] [Related]
34. Relationship between occupational risk factors and severity markers of systemic sclerosis.
Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
[TBL] [Abstract][Full Text] [Related]
35. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.
Merashli M; Alves J; Ames PRJ
Semin Arthritis Rheum; 2017 Apr; 46(5):615-624. PubMed ID: 27838012
[TBL] [Abstract][Full Text] [Related]
37. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
38. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
39. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis.
Swaminathan S; Goldblatt F; Dugar M; Gordon TP; Roberts-Thomson PJ;
Intern Med J; 2008 Dec; 38(12):897-903. PubMed ID: 18422567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
